Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production

Cancer immunology research

Volumn 1, Issue 3, 2013, Pages 158-162

  Pico de Coaña, Yago ^a   Poschke, Isabel ^a   Gentilcore, Giusy ^a   Mao, Yumeng ^a   Nyström, Maria ^a   Hansson, Johan ^a   Masucci, Giuseppe V ^a   Kiessling, Rolf ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARGINASE; ARGINASE I, HUMAN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTAGONISTS AND INHIBITORS; ANTIGEN PRESENTATION; CONTROLLED STUDY; DRUG EFFECTS; ENZYMOLOGY; GRANULOCYTE; HUMAN; IMMUNOLOGY; MALE; MELANOMA; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SKIN NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTINEOPLASTIC AGENTS; ARGINASE; CTLA-4 ANTIGEN; GRANULOCYTES; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 84896523643     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0016     Document Type: Article

References (0)